Published in Leukemia on April 08, 2010
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet (2011) 4.02
Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications. J Biomed Biotechnol (2011) 1.05
Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH. PLoS One (2011) 0.92
Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance. BMC Genomics (2014) 0.86
Identifying candidate oocyte reprogramming factors using cross-species global transcriptional analysis. Cell Reprogram (2013) 0.79
Notch signaling in acute promyelocytic leukemia. Leukemia (2013) 0.79
Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in Myelodysplastic Syndrome. Stem Cells Transl Med (2014) 0.76
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 53.59
Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74
A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A (2004) 44.81
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet (2000) 21.52
Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell (1998) 19.05
Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med (2004) 11.61
BioMart--biological queries made easy. BMC Genomics (2009) 11.06
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell (2005) 9.84
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med (2004) 9.81
Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature (1989) 5.68
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Blood (2008) 3.89
Gene expression profiling of pediatric acute myelogenous leukemia. Blood (2004) 3.77
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci U S A (2000) 3.68
ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci U S A (1998) 3.59
Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell (2001) 3.44
Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell (2002) 3.41
Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell (2003) 3.14
Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci U S A (2002) 3.05
Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature (1996) 2.91
AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci U S A (2001) 2.84
The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol Cell Biol (1995) 2.70
Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer (2004) 1.95
Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. Mol Cell Biol (2002) 1.89
Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. Nature (1996) 1.84
Brn3a-expressing retinal ganglion cells project specifically to thalamocortical and collicular visual pathways. J Neurosci (2005) 1.81
Targeted deletion of the mouse POU domain gene Brn-3a causes selective loss of neurons in the brainstem and trigeminal ganglion, uncoordinated limb movement, and impaired suckling. Proc Natl Acad Sci U S A (1996) 1.71
An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice. Proc Natl Acad Sci U S A (2003) 1.69
Sox-4 facilitates thymocyte differentiation. Eur J Immunol (1997) 1.67
Roles of Sox4 in central nervous system development. Brain Res Mol Brain Res (2000) 1.54
SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res (2008) 1.52
Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc Natl Acad Sci U S A (2009) 1.50
AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development (2008) 1.44
Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer (2003) 1.43
Examination of POU homeobox gene expression in human breast cancer cells. Int J Cancer (1999) 1.42
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res (2008) 1.39
Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR. Blood (2005) 1.34
Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia. Leukemia (2007) 1.29
Mouse Brn-3 family of POU transcription factors: a new aminoterminal domain is crucial for the oncogenic activity of Brn-3a. Nucleic Acids Res (1993) 1.28
Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice. Proc Natl Acad Sci U S A (2004) 1.28
Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia. Blood (2007) 1.28
Caveolin-1 regulates cellular trafficking and function of the glucagon-like Peptide 1 receptor. Mol Endocrinol (2006) 1.23
Enhanced green fluorescent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results in efficient marking of hematopoietic stem cells in vivo. Exp Hematol (2003) 1.20
AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets. PLoS Genet (2008) 1.17
Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia. Proc Natl Acad Sci U S A (2002) 1.16
Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood (1993) 1.15
AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion. Proc Natl Acad Sci U S A (2005) 1.14
Regulation of the expression and activity by progestins of a member of the SOX gene family of transcriptional modulators. J Mol Endocrinol (1999) 1.01
Brn3a regulation of TrkA/NGF receptor expression in developing sensory neurons. Development (2003) 1.01
Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysis. Oncogene (2002) 0.89
Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis. Leukemia (2002) 0.87
Identification of cDNAs for Sox-4, an HMG-Box protein, and a novel human homolog of yeast splicing factor SSF-1 differentially regulated during apoptosis induced by prostaglandin A2/delta12-PGJ2 in Hep3B cells. Biochem Biophys Res Commun (1999) 0.86
Caveolin-1 gene is coordinately regulated with the multidrug resistance 1 gene in normal and leukemic bone marrow. Leuk Res (2004) 0.84
Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia. Br J Haematol (2006) 0.83
Brn-3a/POU4F1 interacts with and differentially affects p73-mediated transcription. Cell Death Differ (2008) 0.81
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia (2011) 4.28
Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell (1994) 4.26
Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev (1995) 4.11
Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med (1998) 4.04
The physician-scientist: career issues and challenges at the year 2000. FASEB J (2000) 3.38
5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia. N Engl J Med (1982) 3.29
RNA processing errors in patients with beta-thalassemia. Proc Natl Acad Sci U S A (1982) 2.99
Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A (1996) 2.93
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia (2013) 2.85
Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci U S A (1996) 2.83
Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood (1997) 2.72
Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem (1993) 2.56
Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci U S A (1999) 2.48
Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A (1995) 2.43
Inducible transcription of five globin genes in K562 human leukemia cells. Proc Natl Acad Sci U S A (1983) 2.35
Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3. Mol Cell Biol (1996) 2.17
Beta O-39 thalassemia gene: a premature termination codon causes beta-mRNA deficiency without affecting cytoplasmic beta-mRNA stability. Blood (1984) 2.17
An enhancer element lies 3' to the human A gamma globin gene. EMBO J (1987) 2.11
Conservation of the primary structure, organization, and function of the human and mouse beta-globin locus-activating regions. Proc Natl Acad Sci U S A (1990) 1.89
How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol (1998) 1.80
Seed versus soil: the importance of the target cell for transgenic models of human leukemias. Blood (1999) 1.73
fgr proto-oncogene mRNA induced in B lymphocytes by Epstein-Barr virus infection. Nature (1986) 1.64
Direct suppression of Stat1 function during adenoviral infection. Immunity (1998) 1.62
5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia. Blood (1983) 1.61
Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci U S A (1995) 1.59
Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J Biol Chem (2001) 1.57
Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem (1992) 1.57
Normal neutrophil function in cathepsin G-deficient mice. Blood (1999) 1.53
DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis. Immunity (2000) 1.52
Genomic organization and chromosomal localization of the human cathepsin G gene. J Biol Chem (1989) 1.52
Advances in thalassemia research. Blood (1984) 1.52
A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1999) 1.50
Functional properties of the beta-globin locus control region in K562 erythroleukemia cells. Blood (1991) 1.48
Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J Clin Invest (1997) 1.45
Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Immunity (1999) 1.37
Effects of paramyxoviral infection on airway epithelial cell Foxj1 expression, ciliogenesis, and mucociliary function. Am J Pathol (2001) 1.32
Transgenic analysis of a 100-kb human beta-globin cluster-containing DNA fragment propagated as a bacterial artificial chromosome. Blood (1999) 1.32
Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice. Proc Natl Acad Sci U S A (2000) 1.30
Granzyme B can cause mitochondrial depolarization and cell death in the absence of BID, BAX, and BAK. Proc Natl Acad Sci U S A (2001) 1.23
Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood (2001) 1.22
A weak upstream promoter gives rise to long human beta-globin RNA molecules. Biochem Biophys Res Commun (1983) 1.20
Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant (2008) 1.19
Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J Biol Chem (1990) 1.19
Function of normal and mutated gamma-globin gene promoters in electroporated K562 erythroleukemia cells. Blood (1990) 1.18
Structure and function of the murine beta-globin locus control region 5' HS-3. Nucleic Acids Res (1992) 1.17
Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad Sci U S A (1994) 1.16
Spin Rabi flopping in the photocurrent of a polymer light-emitting diode. Nat Mater (2008) 1.16
Transfusion haemosiderosis and chelation therapy. Clin Haematol (1982) 1.15
The 5'-flanking region of the human CGL-1/granzyme B gene targets expression of a reporter gene to activated T-lymphocytes in transgenic mice. J Biol Chem (1991) 1.14
The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood (1996) 1.13
Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells. J Immunol (1989) 1.12
Structure and expression of a cluster of human hematopoietic serine protease genes found on chromosome 14q11.2. J Biol Chem (1991) 1.11
Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients? Bone Marrow Transplant (2006) 1.09
Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production. Blood (1986) 1.08
Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation. J Biol Chem (1996) 1.07
Nucleotide sequence and regulation of a human 90-kDa heat shock protein gene. J Biol Chem (1989) 1.06
Mutational profiling in the human genome. Cold Spring Harb Symp Quant Biol (2003) 1.06
Molecular cloning, chromosomal localization, and expression of murine dipeptidyl peptidase I. J Biol Chem (1997) 1.05
Independent formation of DnaseI hypersensitive sites in the murine beta-globin locus control region. Blood (2000) 1.05
A human protein containing a "cold shock" domain binds specifically to H-DNA upstream from the human gamma-globin genes. J Biol Chem (1994) 1.05
Production of fully active recombinant murine granzyme B in yeast. J Biol Chem (1998) 1.02
The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. Genomics (1993) 1.01
DNA methylation and regulation of the human beta-globin-like genes in mouse erythroleukemia cells containing human chromosome 11. Proc Natl Acad Sci U S A (1984) 1.01
Consensus AP-1 and CRE motifs upstream from the human cytotoxic serine protease B (CSP-B/CGL-1) gene synergize to activate transcription. Blood (1993) 1.00
Control of epithelial immune-response genes and implications for airway immunity and inflammation. Proc Assoc Am Physicians (1998) 0.99
Granzyme B plays a critical role in cytotoxic lymphocyte-induced apoptosis. Immunol Rev (1995) 0.99
Could asthma be worsened by stimulating the T-helper type 1 immune response? Am J Respir Cell Mol Biol (2000) 0.98
Stochastic, stage-specific mechanisms account for the variegation of a human globin transgene. Nucleic Acids Res (1998) 0.97
Epitope mapping and specificity of the anti-alpha-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines. Neurosci Lett (2003) 0.96
Human globin gene expression in hybrid 2S MEL X human fibroblast cells. Somat Cell Mol Genet (1984) 0.95
Molecular cloning, chromosomal location, and tissue-specific expression of the murine cathepsin G gene. Blood (1993) 0.95
Augmented inflammatory responses and altered wound healing in cathepsin G-deficient mice. Arch Surg (1998) 0.95
Mouse models of acute promyelocytic leukemia. Curr Opin Hematol (2001) 0.92
Interferon-gamma induces p11 gene and protein expression in human epithelial cells through interferon-gamma-activated sequences in the p11 promoter. J Biol Chem (2003) 0.92
Recombinant retroviral systems for the analysis of drug resistant HIV. Nucleic Acids Res (1993) 0.92
Pancytopenia secondary to oxalosis in a 23-year-old woman. Blood (1998) 0.92
The role of granzyme B cluster proteases in cell-mediated cytotoxicity. Semin Immunol (1997) 0.91
Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia. Ann N Y Acad Sci (1985) 0.90
Transcriptional activation of the human cytotoxic serine protease gene CSP-B in T lymphocytes. Mol Cell Biol (1990) 0.90
Limited engraftment of low-risk myelodysplastic syndrome cells in NOD/SCID gamma-C chain knockout mice. Leukemia (2010) 0.90
Structural variation of the mouse natural killer gene complex. Genes Immun (2010) 0.90
A cluster of hematopoietic serine protease genes is found on the same chromosomal band as the human alpha/delta T-cell receptor locus. Proc Natl Acad Sci U S A (1990) 0.90
Neutral proteinase expression by human mononuclear phagocytes: a prominent role of cellular differentiation. Matrix Suppl (1992) 0.90
Disseminated infection caused by Cunninghamella bertholletiae in a patient with beta-thalassemia. Case report and review of the literature. Ann Intern Med (1985) 0.89
Renal response to graded saline challenge. Am J Physiol (1969) 0.88
Residual cytotoxicity and granzyme K expression in granzyme A-deficient cytotoxic lymphocytes. J Biol Chem (1997) 0.87
The mechanism of the increase in sodium excretion following dopamine infusion. Proc Soc Exp Biol Med (1968) 0.87
DNA methylation and globin gene expression in patients treated with 5-azacytidine. Prog Clin Biol Res (1983) 0.84
Characterization of Ly-6M, a novel member of the Ly-6 family of hematopoietic proteins. Blood (2000) 0.84
Deletions within the mouse beta-globin locus control region preferentially reduce beta(min) globin gene expression. Genomics (2000) 0.84
A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes. Mol Cell Biol (1991) 0.83
Modulation of food intake by peripherally administered amylin. Am J Physiol (1994) 0.83
A-T-rich scaffold attachment regions flank the hematopoietic serine protease genes clustered on chromosome 14q11.2. Blood (1992) 0.82